Hope for pouchitis sufferers: drug and diet combo under study
NCT ID NCT06916390
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tests whether the drug guselkumab, alone or with a special diet, can help people with chronic pouchitis—a painful inflammation of the internal pouch after ulcerative colitis surgery. Twenty adults who have not responded to antibiotics will receive the treatment for 48 weeks. The goal is to see if symptoms like frequent stools and belly cramps can be reduced or eliminated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POUCHITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
university hospitals Leuven
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.